FDA Approves TECNIS PureSee IOL for Cataract Surgery
First FDA-approved extended depth of focus (EDOF) IOL maintaining contrast sensitivity comparable to an aspheric monofocal IOL
-
1
The FDA has approved the TECNIS PureSee IOL, an extended depth of focus intraocular lens for cataract surgery.
-
2
TECNIS PureSee IOL will be available to US patients later this year, enhancing vision restoration opportunities.
-
3
This IOL addresses cataract-related vision loss and presbyopia in a single surgical procedure.
-
4
It is the first FDA-approved EDOF IOL with no warning on loss of contrast sensitivity, maintaining visual clarity.
-
5
97% of patients report minimal visual disturbances post-surgery, reducing their reliance on glasses.
